Blackstone buys stake in Chinese implant maker

The US private equity firm has invested in China’s fast-growing medical device sector, buying a stake Jiangsu-based Xinrong.

Blackstone buys stake in Chinese implant maker

Blackstone has agreed to make a significant investment into Xinrong Best Medical Instrument, a Chinese maker of orthopaedic implants for trauma, spine and joint applications.

The companies did not state the value of the deal nor the ownership split, however a person familiar with the matter said Blackstone is investing just over $100 million and would have influence over decision-making at the company.

China’s orthopaedic implant market will grow from $1.3 billion...

To continue reading, please login or register for free

Click for more on: china | private equity | acquisitions

Print Edition

FinanceAsia Print Edition


  • Green Bonds Southeast Asia

    25 May 2017  |  Singapore
    With Green Bonds globally reaching USD200 billion outstanding in 2016, from as little as 30bn just 4 years ago, can SE Asia corporations and ...
  • 2nd Compliance Summit Southeast Asia

    17 August 2017  |  Singapore
    The 2017 Compliance Summit Southeast Asia will take an in-depth look at the key compliance considerations today with a focus on regulation and new ...